THE COMPREHENSIVE COMPARISON OF THE EFFICACY OF FIRST-LINE DRUGS IN THE TREATMENT OF TYPE II DIABETES: METFORMIN, GLP-1 AGONISTS, AND SGLT2 INHIBITORS. (2025). International Journal of Innovative Technologies in Social Science, 6(3(47). https://doi.org/10.31435/ijitss.3(47).2025.3884